AzTrials
AzTrials

Nasal Continuous Positive Airway PressureNCT05440669

White Noise in Nasal Cpap Application

A study testing white noise in people with Nasal Continuous Positive Airway Pressure, run by Ataturk University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to determine the effect of white noise application on the pain and stress level of newborns receiving oxygen support via nasal CPAP in the Neonatal Intensive Care Unit. The research is a randomized controlled trial. Read more about this study

Who is it for?
Ages 38 to 40 weeks
What is being tested?
white noise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteTurkey (Türkiye)
Study dates
19 Jun 2022to 19 Jan 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 38 to 40 weeks
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • 38-40 weeks of gestation
  • Receiving oxygen support in nasal CPAP
  • Not taking opioids or sedatives 4 hours before the procedure

Who cannot join

  • Not at 38-40 weeks of gestation
  • Not receiving oxygen support in nasal CPAP
  • Taking opioids or sedatives 4 hours before the procedure

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ataturk University Nursing of Faculty

    Erzurum, Center, 25240

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of White Noise on Pain and Stress Level in Nasal Cpap Application

The aim of this study is to determine the effect of white noise application on the pain and stress level of newborns receiving oxygen support via nasal CPAP in the Neonatal Intensive Care Unit. The research is a randomized controlled trial. The population of the study will be infants aged 0-28 days who were hospitalized for treatment in Şanlıurfa Training and Research Hospital between July and December 2022. The research sample; Babies of families who are hospitalized in the Neonatal Intensive Care Unit on the specified dates and meet the research criteria and volunteer to participate in the research will be formed. "Survey Form", "Follow-up Form" and "ALPS Neo Neonatal Pain and Stress Assessment Scale", White Noise, MP 3 Player, and Sound Decibel Measuring Device will be used to collect data.

Read the detailed description

Type of Study: The study is planned experimentally with a randomized control group.

Place and Time of the Research: The research will be carried out between June-December 2022 in Şanlıurfa Training and Research Hospital Neonatal Intensive Care Unit. There are 130 incubators in total, with 53 beds at the 2nd level and 54 beds at the 3rd level. 55 respirators, 4 fully equipped transport incubators with respirators, isolation room, 4 hypothermia devices, 2 Aeeg devices etc. are available. Treatments that can be performed in the Neonatal Intensive Care Unit; respiratory support (ventilator therapy), thoracic tube insertion, blood exchange, total parenteral nutrition, phototherapy, percutaneous catheter applications, patient transport with 24-hour incubators with breathing apparatus, dialysis catheter insertion and follow-up, colostomy care, etc. are treatments. A total of 133 nurses work.

Population and Sampling of the Study: The population of the study will consist of infants aged 0-28 days who will receive oxygen therapy in nasal CPAP by being hospitalized in the Newborn Intensive Care Unit of Şanlıurfa Training and Research Hospital between July and December 2022 due to respiratory distress.

In this study, "prior power analysis" was used to determine sample adequacy. In the power analysis used, "Cohen's standard effect size reference technique" was chosen. In this case, for the t-test in independent groups, it was determined that if the study was advanced with 80 participants in two groups with 40 participants in each group, 80% power could be reached at a significance level of 0.05, at a 95% confidence interval. Against the possibility of data loss, it was decided to collect data from a total of 100 individuals by adding 10% more backup sample to this number. In order to ensure randomization, babies who meet the criteria will be taken to the control group, who are in the first week, and to the experimental group, respectively, and this cycle will be continued until the end of the research, and randomization will be ensured.

Inclusion Criteria for Research

  • 38-40 weeks of gestation
  • Receiving oxygen support in nasal CPAP
  • Not taking opioids or sedatives 4 hours before the procedure.

Data Collection Tools to be Used in the Study: : "Survey Form, Neonatal Pain and Stress Assessment Scale, Follow-up Form, White Noise, MP 3 Player, and Sound Decibel Measuring Device" will be used to collect research data.

Questionnaire Form: In this form, which was prepared by the researcher by examining the literature; There will be questions about the introductory features of the newborn.

ALPS Neo Neonatal Pain and Stress Rating Scale: The "ALPS Neo Neonatal Pain and Stress Rating Scale" was developed in 2014, based on the individualized developmental care of the newborn, in order to evaluate pain and stress in premature and term newborns. In 2017, this scale was adapted to Turkish and its validity and reliability study was conducted. The scale is a 3-point Likert-type scale consisting of 5 parameters: "newborn's facial expression, breathing pattern, tone of the extremities, hand/foot activities, and activity level". As the scores increase, pain and stress increase in the newborn. As a result of the evaluation, "3-5 points indicate the presence of mild pain and stress, and more than 5 points indicate the presence of severe pain and stress".

Follow-up Form: It is a form used to record the newborn's cardiorespiratory parameters (peak heart rate, oxygen saturation), ALPS Neo pain scale, and crying time evaluated during nasal CPAPP.

Intervention Tool to be Used in Research White noise: Dr. Orhan Osman to calm the babies. It was prepared by making use of the album "Happy Baby" prepared by Harvery KARP, which consists of only intrauterine sounds.

Sound decibel meter: It will be used to determine the sound level of the white noise concert. The application will be made so that the level in the environment is 45-55 dB.

Mp3 player: It will be used for listening to white noise. Data Collection The research data will be collected from the babies of the families who agreed to participate in the research after the researcher gave the parents of the patients preliminary information about the research (the purpose of the research, why the research was conducted, the attempt to relieve the neonatal pain with a non-pharmacological method, etc.) and after their written consent was obtained. The purpose of making the patient listen to white noise; It is to reduce the pain and stress level of the procedure to a minimum level by ensuring that the patient calms down.

Experimental Group: Babies in this group will be listened to white noise for five minutes before nasal CPAP is applied.5. After 1 minute, nasal CPAP application will be started. White noise will continue to be listened during the application. Before the application, during the application, after the patient will be evaluated with the ALPS-Neo Neonatal Pain and Stress Rating Scale and the scale and follow-up form will be filled.

Control Group: Nasal CPAP will be routinely applied to babies in this group and the patient will be evaluated with the ALPS Neo Neonatal Pain and Stress Rating Scale before, during and after the procedure, and the scale and follow-up form will be filled.

Evaluation of Data Evaluation of statistics will be done by blinding method. Data will be collected by the researcher. The analysis of the data will be done by the statistician. The data will be sent after making sure that the data is coded in a way that preserves the blinding (without knowing which of the control and experimental groups). SPSS package program will be used for data analysis. The normality distribution of the data will be determined by the Kurtosis and Skewness coefficients. For the analysis of the data, "t-test for normally distributed measurements in the comparison of paired groups with numbers, percentages, mean and standard deviations, and Mann Whitney U test for non-normally distributed measurements" will be used. In the comparison of multiple groups, "Analysis of variance" will be used for normally distributed measurements, and Kruskall Wallis test for non-normally distributed measurements.

Ethical Principles of Research In order to carry out the research, official permission will be obtained from the relevant institution with ethical approval. The purpose of the study will be explained to the parents of the babies with the research group criteria, the questions asked will be answered and their verbal and written consent will be obtained. Parents will be informed that the data collected during the research will be processed anonymously, confidentially, and will not be used outside of the study in question, and that they can leave the study whenever they wish. Since the research is based on the use of data obtained from humans, and therefore, due to the necessity of observing personal rights, the relevant ethical principles "Informed Consent", "Volunteerism" and "Protection of Confidentiality" will be followed.

Being tested
white noise

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • white noiseBehavioural

    white noise will reduce pain and stress in nasal cpap application

Study groups in NCT05440669
Study groupRoleWhat they receive
White NoiseExperimentalwhite noise will reduce pain and stress
Receives: Behavioral: white noise
controlNo interventionwhite noise will not reduce pain and stress

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. ALPS Neo Neonatal Pain and Stress Rating Scale

    The "ALPS Neo Neonatal Pain and Stress Rating Scale" was developed in 2014, based on the individualized developmental care of the newborn, in order to evaluate pain and stress in premature and term newborns. In 2017, this scale was adapted to Turkish and its validity and reliability study was conducted. The scale is a 3-point Likert-type scale consisting of 5 parameters: "newborn's facial expression, breathing pattern, tone of the extremities, hand/foot activities, and activity level". As the scores increase, pain and stress increase in the newborn. As a result of the evaluation, "3-5 points indicate the presence of mild pain and stress, and more than 5 points indicate the presence of severe pain and stress".

    Measured: 9 MONTHS

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jul 2022
  2. Study start19 Jun 2022
  3. Primary completion27 Sep 2022
  4. Study completion19 Jan 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05440669
Sponsor's protocol ID
B.30.2.ATA.0.01.00/448
Status last verified
Mar 2024
First submitted
22 Jun 2022
Last updated
8 Mar 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: THE ARTICLE IS INTENDED TO BE SHARED AFTER IT IS PUBLISHED

Publications

  • Gokturk G, Sarialioglu A. Effect of white noise during nasal continuous positive airway pressure application on newborn's pain and stress levels, physiological parameters, and crying durations: A randomized controlled study. J Pediatr Nurs. 2024 Sep-Oct;78:e330-e337. doi: 10.1016/j.pedn.2024.07.022. Epub 2024 Jul 26.

    PubMed 39060170

Questions about this trial

What is this clinical trial studying?

A study testing white noise in people with Nasal Continuous Positive Airway Pressure, run by Ataturk University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

ALPS Neo Neonatal Pain and Stress Rating Scale (time frame: 9 MONTHS). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05440669, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Mar 2024; AzTrials last refreshed its copy on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in